Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous Drug Reaction Case Reports
- New Drugs: Dutasteride
- AB0442 Real-life experience with belimumab in systemic lupus erythematosus (SLE): control of disease activity and flares in a multicenter cohort
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- JAK inhibitors and alopecia areata
- Generalized maculopapular rash and fever
- Safety of treatment options for spondyloarthritis: a narrative review
- Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatológicas
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Composite biomaterials in immunomodulation: A new era in targeted therapy
- FRI0152 METHOTREXATE TREATMENT PATTERNS IN ADVANCED THERAPY–NAïVE PATIENTS WITH RHEUMATOID ARTHRITIS: CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS IN THE CORRONA REGISTRY
- In silico analysis of ethyl acetate Bruguiera gymnorhiza leaf extracts as an anti-inflammatory agent
- Alopecia Areata Update
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Leflunomide
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- 572 Defining chronic wound types in recessive dystrophic epidermolysis bullosa patients for clinical outcome assessment
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis
- Side effects of methotrexate therapy in patients with rheumatoid arthritis
- Baricitinib: From Rheumatoid Arthritis to COVID‐19
- Case Report: Triple autoimmune overlap: rheumatoid arthritis, systemic lupus erythematosus, and hypereosinophilic asthma with systemic manifestations
- Fibromyalgia, Systemic Lupus Erythematosus (SLE), and Evaluation of SLE Activity